What is the starting dose of Lantus (insulin glargine) for a patient with Type 2 diabetes mellitus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Starting Dose of Lantus (Insulin Glargine) for Type 2 Diabetes

The recommended starting dose of Lantus (insulin glargine) for patients with type 2 diabetes who are not currently treated with insulin is 0.2 units/kg of body weight or up to 10 units once daily. 1

Initial Dosing Guidelines

Basal insulin therapy with Lantus can be initiated using the following approach:

  • Starting dose options:
    • 10 units once daily 2
    • 0.1-0.2 units/kg of body weight once daily 2, 1

For example:

  • A 70 kg patient would start with 7-14 units (at 0.1-0.2 units/kg)
  • For most patients, the simpler approach of starting with 10 units is appropriate

Administration Considerations

  • Administer Lantus subcutaneously once daily at any time of day, but at the same time every day 1
  • Common injection sites include abdominal area, thigh, or deltoid 1
  • Rotate injection sites within the same region to reduce the risk of lipodystrophy 1
  • Lantus should not be diluted or mixed with any other insulin or solution 1

Titration Protocol

After initiating Lantus, dose adjustments should be made based on blood glucose monitoring:

  • Increase dose by 2-4 units every 3-7 days until target fasting blood glucose is achieved 2, 3
  • Target fasting blood glucose: <100 mg/dL (5.5 mmol/L) 2
  • If hypoglycemia occurs, determine the cause and reduce dose by 10-20% 3
  • Watch for signs of overbasalization if basal dose exceeds 0.5 units/kg/day 2

Combination Therapy

When initiating Lantus in type 2 diabetes:

  • Continue metformin and potentially other oral antidiabetic medications 2, 3
  • Basal insulin is typically used with metformin and perhaps one additional noninsulin agent 2
  • Consider GLP-1 receptor agonists before adding prandial insulin if further glycemic control is needed 3

Special Considerations

  • Severe hyperglycemia: Consider starting insulin therapy immediately when blood glucose levels are ≥300-350 mg/dL or HbA1c levels are 10-12%, especially if symptomatic 2
  • Elderly patients or those with renal impairment: Consider starting with lower doses (0.1 units/kg/day) to minimize hypoglycemia risk 3
  • Switching from other insulin regimens:
    • When switching from twice-daily NPH insulin to once-daily Lantus, the recommended starting Lantus dosage is 80% of the total NPH dosage 1
    • When switching from once-daily NPH insulin to once-daily Lantus, the recommended starting Lantus dosage is the same as the NPH dosage 1

Common Pitfalls to Avoid

  1. Delayed dose titration: Timely dose titration after insulin initiation is crucial for achieving glycemic targets 2
  2. Using insulin as a threat: Avoid describing insulin therapy as a sign of personal failure or punishment 2
  3. Overbasalization: Watch for signs such as basal dose >0.5 units/kg, high bedtime-morning glucose differential (≥50 mg/dL), or hypoglycemia 2
  4. Inadequate monitoring: During changes to insulin regimen, increase the frequency of blood glucose monitoring 1
  5. Mixing insulins: Do not dilute or mix Lantus with any other insulin or solution 1

Remember that insulin therapy needs to be individualized based on the patient's metabolic needs, blood glucose monitoring results, and glycemic control goals, with adjustments made under medical supervision.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Insulin Therapy Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.